NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/22/2019
Back to search
Official data from USPTO
PHARMAXIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
02/22/2019
Classification
Registered
Trademark type
Combined
Nice classes
5, 10
Filing date
08/11/2006
Registration date
02/10/2009
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/22/2019
Last transaction
02/22/2019
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
5
Owner type
03
Owner location
Frenchs Forest, N.S.W., AU
Examiner
ALLEN, BENJAMIN
Law office
M50
Current location
TMO LAW OFFICE 114
Holders and representatives
Holders
Pharmaxis Ltd
Representatives
Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations to treat and prevent diseases and disorders associated with the respiratory system; pharmaceutical preparations to treat and prevent chronic obstructive pulmonary diseases and disorders; pharmaceutical preparations for the treatment and prevention of bronchiectasis; pharmaceutical preparations for the treatment and prevention of chronic bronchitis; and pharmaceutical preparations for the treatment and prevention of cystic fibrosis; inhalers filled with pharmaceutical preparations to treat and prevent diseases and disorders associated with the respiratory system; inhalers filled with pharmaceutical preparations to treat and prevent chronic obstructive pulmonary diseases and disorders; inhalers filled with pharmaceutical preparations for the treatment and prevention of bronchiectasis; inhalers filled with pharmaceutical preparations for the treatment and prevention of chronic bronchitis; inhalers filled with pharmaceutical preparations for the treatment and prevention of cystic fibrosis
Class 10
Inhalers for medical purposessold empty; inhalers for therapeutic purposessold empty; pressurized metered dose medical inhalerssold empty; dry powder inhalers for medical or therapeutic usesold empty; medical inhalers sold empty; apparatus for administering drugs or pharmaceutical preparations by inhalationnebulizers for respiration therapy and medical apparatus for facilitating the inhalation of pharmaceutical preparations; and drug delivery apparatusdrug delivery systems; replacement parts and fittings for the aforementioned goods
Publications
History of USPTO decisions and trademark events.
36 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02/22/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/22/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/21/2019
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
01/21/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
01/21/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/10/2018
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/21/2015
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/21/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/21/2015
E815
TEAS SECTION 8 & 15 RECEIVED
02/06/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
02/10/2009
TMBN
TTAB RELEASE CASE TO TRADEMARKS
12/31/2008
OP.T
OPPOSITION TERMINATED NO. 999999
12/31/2008
OP.D
OPPOSITION DISMISSED NO. 999999
12/31/2008
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/28/2008
OP.I
OPPOSITION INSTITUTED NO. 999999
04/23/2008
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
01/18/2008
PUBO
PUBLISHED FOR OPPOSITION
12/25/2007
NPUB
NOTICE OF PUBLICATION
12/05/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/19/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/16/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/14/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/14/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/12/2007
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/21/2007
GNRT
NON-FINAL ACTION E-MAILED
08/21/2007
CNRT
NON-FINAL ACTION WRITTEN
08/21/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/31/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/31/2007
ALIE
ASSIGNED TO LIE
07/31/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/12/2007
GNRT
NON-FINAL ACTION E-MAILED
01/12/2007
CNRT
NON-FINAL ACTION WRITTEN
01/12/2007
DOCK
ASSIGNED TO EXAMINER
01/06/2007
NWAP
NEW APPLICATION ENTERED
08/16/2006
Continuous trademark protection
Get notified about every new filing that threatens PHARMAXIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.